Sensei Biotherapeutics, Inc. Common Stock
SNSENASDAQUS Equity
$13.85▼ $3.09 (−22.28%)
Live1h—
24h▼ 22.3%
7d▼ 0.4%
14d▼ 0.4%
30d▼ 0.4%
1y▲ 80.6%
🏦Market Cap
$211B
Large Cap
📈Revenue Growth (YoY)
+32.9%
High Growth
📊Gross Margin
43.6%
Healthy
💵FCF Margin
23.7%
Strong
⚖️P/S Ratio
12.9x
Elevated
Otter Score
59
Weak
Earnings
Q2 · 2026Reported 2026-05-15Earnings Per Share
Actual
-131.45
Expected
-0.62
miss
−21101.60%
YoY −2334.30%
Revenue
Actual
—
Expected
—
—
—
Consensus estimates
Recent quarters
Q2 2026
-131.45
miss
Q1 2026
-3.74
beat
Q4 2025
-3.62
beat
Q3 2025
-3.91
beat